PROPEL treatment is an FDA-approved device which acts as a spring-like implant that expands to prop open the sinus, while gradually delivering an anti-inflammatory medication directly to the sinus lining while it is healing. The implant then dissolves, leaving a healthy, open sinus area.
PROPEL treatment is clinically proven to improve surgical outcomes for chronic sinusitis sufferers.
When placed in the sinus following surgery, PROPEL treatment decreases scarring and inflammation, reducing the need for additional surgical procedures as well as oral steroids and their potential side effects. PROPEL treatment is also proven to reduce frank polyposis by 46% and need for oral steroids by 40%.
The spring-like PROPEL implant props open the ethmoid sinus to maintain the surgical opening, delivers an anti-inflammatory medication directly to the sinus lining, and then dissolves, avoiding the need for removal.
Talk with your doctor to see if PROPEL is the right option for you.